OMCL - Omnicell, Inc. -  [ ]

Ticker Details
Omnicell, Inc.
Omnicell Inc provides automation and business analytics software solutions for patient-centric medication and supplies management across the entire healthcare continuum, from the acute care hospital setting to post-acute skilled nursing.
IPO Date: August 7, 2001
Sector: Healthcare
Industry: Health Care Technology
Market Cap: $2.02B
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.62 | 1.68%
Avg Daily Range (30 D): $0.62 | 1.52%
Avg Daily Range (90 D): $0.71 | 1.78%
Institutional Daily Volume
Avg Daily Volume: .3M
Avg Daily Volume (30 D): .46M
Avg Daily Volume (90 D): .49M
Trade Size
Avg Trade Size (Sh.): 83
Avg Trade Size (Sh.) (30 D): 42
Avg Trade Size (Sh.) (90 D): 44
Institutional Trades
Total Institutional Trades: 6,402
Avg Institutional Trade: $2.61M
Avg Institutional Trade (30 D): $2.1M
Avg Institutional Trade (90 D): $2.27M
Avg Institutional Trade Volume: .05M
Avg Institutional Trades (Per Day): 2
Market Closing Trades
Avg Closing Trade: $3.36M
Avg Closing Trade (30 D): $3.37M
Avg Closing Trade (90 D): $3.64M
Avg Closing Volume: 56.14K
 
News
Apr 14, 2026 @ 5:11 PM
10 Discounted Stocks That Could Surprise This Earn...
Source: David Wagner
Apr 9, 2026 @ 8:57 AM
Robotic Pharmacy Prescription Market Research and ...
Source: Researchandmarkets.Com
Jan 5, 2026 @ 8:33 PM
Omnicell Executive Trims Holdings in $244,000 Sale...
Source: Sara Appino
Aug 26, 2025 @ 11:00 AM
Evoke Pharma and EVERSANA Expand GIMOTI® Access...
Source: Daniel Kontoh-Boateng
Jul 21, 2025 @ 2:00 PM
Pharmacy Automation Market Surges with 10.12% CAGR...
Source: Towards Healthcare
Financials
  TTM Q1 2026 Q4 2025
Basic EPS $.44 $.25 $-.05
Diluted EPS $.44 $.25 $-.05
Revenue $1.23B $309.88M $313.98M
Gross Profit $532.87M $140.36M $130.33M
Net Income / Loss $20.43M $11.36M $-2.03M
Operating Income / Loss $33.63M $16.85M $.42M
Cost of Revenue $692.19M $169.52M $183.66M
Net Cash Flow $-123.44M $39.93M $25.58M
PE Ratio